CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (NYSE-AMEX: PLX), today announced that Dr. David Aviezer, the Company’s President and Chief Executive Officer, will be presenting at the Oppenheimer 10th Annual Israeli Conference and the European Human Genetics Conference 2009. Additionally, the Company will be participating in the 2009 BIO International Convention as part of the Israeli delegation.
